MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs ...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).

Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...

Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.

Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...